lobbying_activities: 3330210

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3330210	419c5fe0-3553-45fc-80ac-6d8098aee672	Q1	EAGLE POINT STRATEGIES LLC	401108457	OBJECT PHARMA	2025	first_quarter	VET	Issues related to the development of neurotoxin treatment for PTSD and other mental health related disorders in regards to veterans.	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2025-04-09T11:05:52-04:00